For Serbian mother Timea Gajodi, watching her 11-month-old baby grow is a nerve-wracking race against the clock to raise more than $2 million to treat his rare disease. 

Without treatment, it results in death or the need for permanent ventilation by the age of two in 90 per cent of cases

Her only way to find such a sum has been to put her baby’s face on a billboard in the type of fundraising campaign that has taken Serbia by storm in recent years, raising millions for medical treatments abroad.

Handout picture released courtesy of the family, shows 11-month-old baby Oliver Gajodi, suffering from a spinal muscular atrophy, in a hospital in Novi Sad.

Her son Oliver suffers from spinal muscular atrophy (SMA) which makes the muscles weaker and affects about one in 10,000 births. 

Without treatment, it results in death or the need for permanent ventilation by the age of two in 90 per cent of cases. 

“I never know what’s waiting for me when I go into the intensive care unit. He is currently stable, but it doesn’t mean he will be in half an hour,” Gajodi told AFP of her son, who is on a ventilator in a hospital in the northern city of Novi Sad.

“I just want to save his life,” the 28-year-old mother added.

Oliver has received treatment in Serbia which his mother said helped him “immensely”.

Novartis cites 'transformative' data on Zolgensma as it rolls out SMA gene therapy in Europe

But she has her hopes pinned on another drug, which he would have to go abroad to receive but, she believes, would “halt the disease’s progression altogether”.

Known as the “world’s most expensive drug”, Zolgensma is a one-time gene therapy.

Pharmaceutical giant Novartis which produces it says the cost reflects the fact that gene therapy is a transformative new type of treatment and is 50 per cent cheaper than current alternatives.

Selling homes 

Gajodi’s fundraising campaign is powered by text messages, allowing people to donate 200 dinars each, around €1.7.

Oliver is one of five babies in Serbia suffering from SMA whose parents have turned to the public in this way since May.

Their campaign has attracted near-daily media coverage. 

Within half a year, the poor Balkan country – where average wages are under €483 a month – has raised some €8 million to secure the treatment for four of the babies.

More than 100,000 people have also signed an online petition demanding local municipalities divert the budget for this year’s coronavirus-plagued New Year’s Eve celebrations to helping the five infants. 

Seven municipalities have done so, though not big cities like Belgrade and Novi Sad.

Oliver is the last of the five babies and has so far received around 300,000 text donations, amounting to more than €150,000. 

According to local media, some donors have gone as far as selling their summer homes to help or auctioning off other assets online.

Earlier this month, half a million viewers logged on to watch Serbian pop star and 2007 Eurovision winner Marija Serifovic’s online fundraising concert for 14-month-old Minja Matic, also suffering from SMA.

“I will sing as long as I have a voice, until we collect the money for Minja,” Serifovic said. 

Shortly after, the family announced it had met its target.

Parents panic 

Billboards with children’s faces have become a regular sight across Serbia and even refugees have organised fundraising in four migrant reception centres.

Not all the campaigns are for such costly treatments.

Healthcare in Serbia is free but has limited reach when it comes to innovative or consistent treatments, humanitarian organisations say. 

Katarina Danojlic, of the Podrzi zivot fundraising foundation, said that parents contact her organisation daily, often in a panic because they have been shrugged off by the state.

“If the health system did its job, our organisation wouldn’t have to exist,” she told AFP.

Serbia has a budget for funding treatment abroad for children with rare diseases but, according to humanitarian organisations, it isn’t enough.

Slavica Vasiljevic, whose six-year-old son Jovan has cerebral palsy, raised almost €60,000 for him to be treated in neighbouring Croatia.

“After the treatment, he was cognitively better, with more refined motor skills, and he got much better in chewing his food,” she told AFP. 

“Now he can even stand on his own, for a few seconds,” Vasiljevic said, with a wide smile.

Critics accuse the government of misplaced priorities, citing the millions spent on projects like building a musical water fountain in the capital.

But Serbian President Aleksandar Vucic has said that fundraising campaigns are common in “almost all Western countries”.

He also pointed out that the drug Spinraza for treating SMA that some doctors claim to be just as effective as Zolgensma was available in Serbia.

One commentator on social media, though, proposed a different solution: “Let’s pay politicians by sending texts, and treat children with money from the budget”.